National Research Solidifies Dividend Amid Insider Buying and Contract Growth
National Research Corporation (NASDAQ:NRC), carrying on business operations as NRC Health, is a healthcare organization based in Nebraska.
National Research Corp (NRC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 371,984 | $6,249,331 | +1% | 0.01% |
| 2. | AQR Capital Management Cliff Asness | 201,396 | $3,383,453 | +87% | 0% |
| 3. | Citadel Investment Group Ken Griffin | 107,195 | $1,800,876 | -42% | 0% |
| 4. | Millennium Management Israel Englander | 53,810 | $904,008 | +28% | 0% |
| 5. | Quantinno Capital Hoon Kim | 26,092 | $438,347 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.97 | 771 | $9,999.87 | 771 | 2025-07-31 | Filing | |
| $13.59 | 2,500 | $33,973.75 | 35,003 | 2025-05-12 | Filing | |
| $19.31 | 5,494,440 | $106,097,636.40 | 5,494,440 | 2018-02-15 | Filing | |
| $29.15 | 300 | $8,745.00 | 4,104 | 2010-12-13 | Filing | |
| $29.10 | 200 | $5,820.00 | 3,804 | 2010-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.54 | 598,653 | $24,269,392.62 | 3,854,284 | 2024-03-01 | Filing | |
| $40.20 | 2,614 | $105,092.47 | 3,831,362 | 2024-01-05 | Filing | |
| $41.22 | 4,600 | $189,617.06 | 3,833,976 | 2024-01-04 | Filing | |
| $41.53 | 364,625 | $15,142,876.25 | 4,452,937 | 2024-01-03 | Filing | |
| $41.77 | 120,139 | $5,018,758.67 | 3,838,576 | 2024-01-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,986,725 | $50,176,987 | 0.12% | |
| 2. | 1,192,716 | $20,037,629 | 0% | |
| 3. | 919,555 | $15,448,524 | 0% | |
| 4. | 871,551 | $14,642,056 | 0% | |
| 5. | 531,199 | $8,924,078 | 0% |
News See All
10 Low Risk Dividend Paying Stocks for June 2025
The month of June is almost over, and the market’s spotlight is well focused on the Fed’s latest meeting. The interest rates are expected to hold steady for now.
Conestoga Capital Advisors Sold National Research Corp. (NRC), as it Fell Short of Expectations
Conestoga Capital Advisors, an asset management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
National Research Corporation (NASDAQ:NRC) Q1 2024 Earnings Call Transcript
Operator: Good morning or good afternoon all, and welcome to the National Research Corporation First quarter earnings call. My name is Adam, and I'll be your operator today. [Operator instructions].
National Research Corporation (NASDAQ:NRC) Q4 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the National Research Corporation Fourth Quarter and Year-End 2023 Earnings Call. My name is Drew, and I'll be the operator on today's call.
National Research Corporation (NASDAQ:NRC) Q3 2023 Earnings Call Transcript
Operator: Hello, everyone, and welcome to the National Research Corporation Third Quarter 2023 Earnings Call. My name is Charlie and I’ll be coordinating the call today.
National Research Corporation (NASDAQ:NRC) Q2 2023 Earnings Call Transcript
Operator: Hello and welcome to today’s National Research Corporation Second Quarter 2023 Earnings Call. My name is Bailey and I will be your moderator for today.
National Research Corporation (NASDAQ:NRC) Q1 2023 Earnings Call Transcript
Operator: Hello everyone and welcome to the National Research Corporation's First Quarter 2023 Earnings Call. My name is Daisy and I'll be coordinating your call today.
National Research Corporation (NASDAQ:NRC) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to the National Research Corporation Fourth Quarter 2022 Earnings Call. My name is Elliot and I'll be coordinating your call today. .
Conestoga Capital Maintains National Research Corp. (NRC) Position Despite its Poor Returns
Conestoga Capital Advisors, a boutique, independent investment management firm, published its fourth-quarter 2020 ‘Small Cap Growth & SMid Cap Growth’ Investor Letter – a copy of which can be downloaded...
Billionaire Hedge Funds
